Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1957 1
1959 1
1961 2
1962 2
1963 3
1964 9
1966 2
1967 4
1968 2
1969 2
1970 1
1971 3
1972 5
1973 2
1974 4
1975 12
1976 4
1977 8
1978 6
1979 6
1980 11
1981 10
1982 15
1983 18
1984 23
1985 13
1986 24
1987 15
1988 23
1989 21
1990 35
1991 27
1992 24
1993 38
1994 46
1995 45
1996 58
1997 65
1998 58
1999 72
2000 71
2001 73
2002 86
2003 87
2004 107
2005 127
2006 168
2007 167
2008 170
2009 250
2010 183
2011 218
2012 204
2013 215
2014 269
2015 337
2016 338
2017 378
2018 389
2019 451
2020 550
2021 582
2022 562
2023 477
2024 191

Text availability

Article attribute

Article type

Publication date

Search Results

6,430 results

Results by year

Filters applied: . Clear all
Page 1
[Clinical Role of M Protein in Multiple Myeloma and Lymphoma --Review].
Zhang LY, Xiang YH, Li YY, Zhang J. Zhang LY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Aug;30(4):1281-1285. doi: 10.19746/j.cnki.issn.1009-2137.2022.04.050. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022. PMID: 35981399 Review. Chinese.
M protein is often expressed in multiple myeloma and also can be detected in several lymphoma such as Waldenstrm macroglobulinaemia. ...This article reviews the role of M protein in the progression and prognosis of multiple myeloma and lymphoma, and di …
M protein is often expressed in multiple myeloma and also can be detected in several lymphoma such as Waldenstrm macroglobulin …
[Plasmablastic lymphoma presenting clinical symptoms similar to plasmablastic myeloma].
Nakaya A, Nagate Y, Toda J, Yamashita Y, Hirose Y, Mori K, Shibayama H. Nakaya A, et al. Rinsho Ketsueki. 2023;64(4):260-264. doi: 10.11406/rinketsu.64.260. Rinsho Ketsueki. 2023. PMID: 37121769 Japanese.
Biopsy of a head mass led to the diagnosis of plasmablastic lymphoma (PBL), an aggressive B-cell lymphoma with plasma cell phenotypes but no B-cell antigen expression. Because the tumor cells have plasmablastic morphologies, it is difficult to distinguish PBL from p …
Biopsy of a head mass led to the diagnosis of plasmablastic lymphoma (PBL), an aggressive B-cell lymphoma with plasma cell phe …
Myeloma and lymphoma.
Mulligan ME. Mulligan ME. Semin Musculoskelet Radiol. 2000;4(1):127-35. doi: 10.1055/s-2000-6860. Semin Musculoskelet Radiol. 2000. PMID: 11061697 Review.
This article reviews current information regarding myeloma, especially multiple myeloma and plasmacytoma as well as primary lymphoma of bone (PLB). The emphasis is on diagnostic imaging, including radiography, computed tomography (CT), magnetic resonance (MR) …
This article reviews current information regarding myeloma, especially multiple myeloma and plasmacytoma as well as primary …
A decade of clinical lymphoma, myeloma & leukemia.
Allen D. Allen D. Clin Lymphoma Myeloma Leuk. 2010 Dec;10(6):409. doi: 10.1016/S2152-2650(11)70041-6. Clin Lymphoma Myeloma Leuk. 2010. PMID: 21156458 No abstract available.
Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma.
Ahn JS, Okal R, Vos JA, Smolkin M, Kanate AS, Rosado FG. Ahn JS, et al. J Clin Pathol. 2017 Sep;70(9):775-780. doi: 10.1136/jclinpath-2016-204294. Epub 2017 Mar 1. J Clin Pathol. 2017. PMID: 28249941
AIMS: To determine the utility of clinical, morphological and phenotypical features in the differential diagnosis of plasmablastic lymphoma and myeloma with plasmablastic features. ...CONCLUSIONS: The distinction between plasmablastic lymphoma from pla …
AIMS: To determine the utility of clinical, morphological and phenotypical features in the differential diagnosis of plasmablastic …
Lymphoma and myeloma in older patients.
Westin EH, Longo DL. Westin EH, et al. Semin Oncol. 2004 Apr;31(2):198-205. doi: 10.1053/j.seminoncol.2003.12.030. Semin Oncol. 2004. PMID: 15112150 Review.
Lymphoma and myeloma represent an increasingly important cause of morbidity and mortality in the older patient group. ...Significant new data will be required to document and elucidate the differences and use them to tailor therapy to discrete disease entities. Incr
Lymphoma and myeloma represent an increasingly important cause of morbidity and mortality in the older patient group. ...Signi
Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma.
Meier J, Jensen JL, Dittus C, Coombs CC, Rubinstein S. Meier J, et al. Blood Rev. 2022 Nov;56:100986. doi: 10.1016/j.blre.2022.100986. Epub 2022 Jun 22. Blood Rev. 2022. PMID: 35753868 Review.
CH is common at the time of diagnosis in patients with blood cancers, including multiple myeloma (MM) and lymphoma. The presence of CH mutations correlates with IL-6 mediated inflammation and may result in lymphoma or MM modulation through microenvironment ef …
CH is common at the time of diagnosis in patients with blood cancers, including multiple myeloma (MM) and lymphoma. The presen …
6,430 results